West Lafayette, IN – According to filings with the U.S. Securities and Exchange Commission, Neurava is raising $1,244,997.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jay Shah played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Neurava
Leveraging groundbreaking epilepsy and SUDEP research, Neurava is working to develop a first of its kind, wearable diagnostic for epilepsy patients, including those at risk of SUDEP. N1 records key biological signals related to epilepsy and SUDEP with wireless alerts sent to caregivers allowing preventative action. Neurava understands the importance of reliably monitoring and alerting impending risk in real-time. We strive to give you an assured feeling of continuous and unwavering care. All recorded data can be wirelessly transmitted to physicians to expedite formulation of treatment and management plans.

To learn more about Neurava, visit http://neurava.org/

Contact:
Jay Shah, Chief Executive Officer
281-995-8055
https://www.linkedin.com/in/-jay-shah/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved